April 2018
A Message from the President - April 2018This has been a busy two months since the 2018 Tandem Meetings for ASBMT. The transition to SmithBucklin from EAI, the previous ASBMT association management company, is now complete. The leadership of ASBMT is absolutely delighted with how easy and uneventful the transition went. This is a testament to not only David Schmahl and Janet Rapp and their team at SmithBucklin but also to the outgoing ASBMT Executive Director, Ken Luurs, EAI, and ASBMT President-Elect Navneet Majhail, who led this transition effort from the ASBMT side. READ MORE
The Annual ASBMT Fall Clinical Education Conference for NPs, PAs and Fellows
Please join us for a multi-day conference for NPs, PAs, fellows and junior faculty focused on the care of blood and marrow transplantation patients. A few highlights in this year’s agenda include clinical care advancements, a “Best of Tandem” review and a half-day of pediatric BMT lectures. This conference will be held in conjunction with Sarah Cannon Blood Cancer Network and the National Marrow Donor Program (NMDP)/Be the Match.
READ MORE
Highlights of Second Annual HCT Survivorship Special Interest Group Meeting at Tandem 2018
The ASBMT HCT Survivorship Special Interest Group (SIG) convened its second annual meeting during Tandem in Salt Lake City, and it was a tremendous success. The meeting was well attended with more than 70 attendees with substantial interest in addressing the survivorship and late effect needs of hematopoietic stem-cell transplant survivors and their caregivers. READ MORE
Policy Perspective - April 2018First, let’s talk logistics. Due to the management firm transition (read more about that decision in the March newsletter President’s Message), ASBMT staff have new emails. You can now reach me at SFarnia@asbmt.org, and I encourage you to please update your address book, as my prior email will expire soon. Normally, the lead story in the April policy column would be an overview of key issues noted in the released Medicare Inpatient Prospective Payment System (IPPS) Proposed Rule and a request for readers to send in comments on the relevant points of concern. READ MORE
4th International Workshop on Biology, Prevention and Treatment of Relapse after Hematopoietic Stem-Cell Transplant
Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with hematopoietic stem-cell transplantation. Register today for the 4th International Workshop on Biology, Prevention and Treatment of Relapse after HSCT, taking place September 21-22, 2018 in Chicago. READ MORE
Also in this issue:
Clinical Research
Tranlational Science Studies
April ASBMT Self-Directed Learning Quiz
Association News
Calendar of Events